These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26398827)

  • 41. Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose.
    Cheng G
    PET Clin; 2018 Jan; 13(1):73-81. PubMed ID: 29157387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inter-comparison of 18F-FDG PET/CT standardized uptake values in Korea.
    Park HH; Park DS; Kweon DC; Lee SB; Oh KB; Lee JD; Jin GH
    Appl Radiat Isot; 2011 Jan; 69(1):241-6. PubMed ID: 20933430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Positron emission tomography in the diagnosis and follow up of non-small cell lung cancer].
    Vaylet F; Rivière F; Le Floch H; Bonnichon A; Mairovitz A; Staub E; Bonardel G; Margery J; Mantzarides M; Marotel C; Foehrenbach H
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S35-9. PubMed ID: 18235392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.
    Marom EM; Munden RF; Truong MT; Gladish GW; Podoloff DA; Mawlawi O; Broemeling LD; Bruzzi JF; Macapinlac HA
    J Thorac Imaging; 2006 Aug; 21(3):205-12. PubMed ID: 16915065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer.
    Xu X; Yu J; Sun X; Yang G; Li K; Fu Z; Han A; Zheng J
    Am J Clin Oncol; 2008 Oct; 31(5):470-5. PubMed ID: 18838884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer.
    Dooms C; van Baardwijk A; Verbeken E; van Suylen RJ; Stroobants S; De Ruysscher D; Vansteenkiste J
    J Thorac Oncol; 2009 Jul; 4(7):822-8. PubMed ID: 19487964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.
    Kased N; Erasmus JJ; Komaki R; Cox JD
    J Thorac Oncol; 2008 May; 3(5):534-8. PubMed ID: 18449010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
    Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE
    Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
    Berghmans T; Dusart M; Paesmans M; Hossein-Foucher C; Buvat I; Castaigne C; Scherpereel A; Mascaux C; Moreau M; Roelandts M; Alard S; Meert AP; Patz EF; Lafitte JJ; Sculier JP;
    J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?
    Buck AK; Glatting G; Reske SN
    J Nucl Med; 2004 Aug; 45(8):1274-6. PubMed ID: 15299047
    [No Abstract]   [Full Text] [Related]  

  • 51. Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    van den Hoff J; Hofheinz F
    J Nucl Med; 2015 Oct; 56(10):1635-6. PubMed ID: 26112026
    [No Abstract]   [Full Text] [Related]  

  • 52. Autocontouring versus manual contouring.
    Hatt M; Visvikis D; Le Rest CC
    J Nucl Med; 2011 Apr; 52(4):658; author reply 658-9. PubMed ID: 21421728
    [No Abstract]   [Full Text] [Related]  

  • 53. Positron emission tomography helps in excluding distant lesions in a case of mesothelioma.
    Thomas A; Singh A; Greenspan B
    Clin Nucl Med; 2005 Jan; 30(1):64-5. PubMed ID: 15604981
    [No Abstract]   [Full Text] [Related]  

  • 54. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; Shen C; DeCamp MM
    Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with advanced non-small cell lung cancer: single center experience.
    Inal A; Kucukoner M; Kaplan MA; Urakci Z; Karakus A; Komek H; Dostbil Z; Isikdogan A
    J BUON; 2012; 17(4):724-8. PubMed ID: 23335532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
    Duan Y; Li J; Zhang Y; Wang W; Sun X; Fan T; Shao Q; Xu M; Guo Y; Shang D
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):623-30. PubMed ID: 25754243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
    Li M; Liu N; Hu M; Shi F; Yuan S; Zhang P; Fu Z; Yang G; Yu J
    Lung Cancer; 2009 Mar; 63(3):383-6. PubMed ID: 18635284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    Hoang JK; Hoagland LF; Coleman RE; Coan AD; Herndon JE; Patz EF
    J Clin Oncol; 2008 Mar; 26(9):1459-64. PubMed ID: 18349396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
    Liu J; Dong M; Sun X; Li W; Xing L; Yu J
    PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.